Westfield Capital Management Co. LP grew its position in shares of Globe Life Inc. (NYSE:GL – Free Report) by 41.4% in the fourth quarter, Holdings Channel reports. The fund owned 608,813 shares of the company’s stock after buying an additional 178,171 shares during the quarter. Westfield Capital Management Co. LP’s holdings in Globe Life were worth $85,149,000 at the end of the most recent reporting period.
Other institutional investors also recently bought and sold shares of the company. CYBER HORNET ETFs LLC bought a new stake in Globe Life in the second quarter worth $28,000. MUFG Securities EMEA plc bought a new stake in Globe Life in the second quarter worth $31,000. Torren Management LLC bought a new stake in Globe Life in the fourth quarter worth $37,000. Banque Cantonale Vaudoise bought a new stake in Globe Life in the third quarter worth $50,000. Finally, Center for Financial Planning Inc. bought a new stake in Globe Life in the third quarter worth $51,000. 81.61% of the stock is currently owned by institutional investors.
Globe Life Stock Up 2.2%
NYSE:GL opened at $154.49 on Friday. Globe Life Inc. has a twelve month low of $116.73 and a twelve month high of $157.92. The company has a market cap of $11.99 billion, a price-to-earnings ratio of 10.68 and a beta of 0.49. The stock has a fifty day simple moving average of $150.03 and a 200-day simple moving average of $143.32. The company has a current ratio of 0.07, a quick ratio of 0.07 and a debt-to-equity ratio of 0.38.
Globe Life Dividend Announcement
The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Monday, July 6th will be given a dividend of $0.33 per share. This represents a $1.32 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, July 6th. Globe Life’s dividend payout ratio (DPR) is 9.13%.
Analyst Ratings Changes
GL has been the subject of a number of analyst reports. Wells Fargo & Company raised their price target on Globe Life from $171.00 to $172.00 and gave the stock an “overweight” rating in a research report on Friday, April 10th. Texas Capital upgraded Globe Life to a “strong-buy” rating in a research report on Wednesday, March 18th. Morgan Stanley raised their price target on Globe Life from $176.00 to $181.00 and gave the stock an “overweight” rating in a research report on Thursday, May 21st. Truist Financial raised their price target on Globe Life from $180.00 to $185.00 and gave the stock a “buy” rating in a research report on Friday, April 24th. Finally, Weiss Ratings upgraded Globe Life from a “buy (b-)” rating to a “buy (b)” rating in a research report on Wednesday, May 13th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $174.11.
Insiders Place Their Bets
In related news, CEO Frank M. Svoboda sold 20,000 shares of Globe Life stock in a transaction dated Friday, May 22nd. The stock was sold at an average price of $156.68, for a total value of $3,133,600.00. Following the completion of the sale, the chief executive officer directly owned 54,020 shares in the company, valued at $8,463,853.60. The trade was a 27.02% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, EVP Michael Clay Majors sold 34,000 shares of Globe Life stock in a transaction dated Friday, April 24th. The shares were sold at an average price of $153.81, for a total value of $5,229,540.00. Following the completion of the sale, the executive vice president owned 53,518 shares of the company’s stock, valued at $8,231,603.58. The trade was a 38.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 105,929 shares of company stock valued at $16,382,450 in the last three months. 2.11% of the stock is owned by company insiders.
Globe Life Company Profile
Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.
The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.
See Also
- Five stocks we like better than Globe Life
- Buy the Dip? Broadcom’s AI Moat Is Wider Than Ever
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
Want to see what other hedge funds are holding GL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Globe Life Inc. (NYSE:GL – Free Report).
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.
